SEL1L and neurodevelopmental disorder: In humans, SEL1L ERAD has been reported to be involved in children’s neurodevelopmental disorders, such as developmental delay, intellectual disability, microcephaly, facial dysmorphisms, hypotonia, and/or ataxia (40).